Tenaya Therapeutics TNYA Cash Flow Statement (2020-2026)

NASDAQ TNYA
$0.70 +0.01 (+0.98%)
At close: Aug 21, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-18.26M-26.15M-31.06M-28.40M-30.70M-33.52M-31.74M-33.27M-29.14M-29.93M-32.23M-29.43M-25.63M-23.84M-26.86M-23.28M-20.27M-20.18M-19.27M-43.39M
Share-based Compensation (Quarter)
0.97M1.05M2.09M3.01M3.17M3.19M3.51M3.83M4.01M3.95M4.22M4.61M3.91M3.76M3.73M3.63M2.93M-9.20M2.20M1.70M
Asset Writedowns and Impairment (Quarter)
21.82M
Cash from Operations (Quarter)
-3.55M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.31M0.32M0.33M0.46M0.71M0.74M0.75M0.78M0.80M0.81M0.80M0.82M1.03M0.74M0.60M0.61M0.62M0.64M0.65M0.67M
Depreciation & Amortization (CF) (Quarter)
0.75M0.79M0.97M1.30M2.09M2.12M2.13M2.19M2.18M2.18M2.15M2.12M2.10M2.09M2.66M2.08M1.86M1.83M1.76M1.70M
Change in Working Capital
Change in Receivables (Quarter)
-10.26M
Change in Account Payables (Quarter)
0.99M
Change in Accured Expenses (Quarter)
1.58M
Other Working Capital Changes (Quarter)
-0.74M
Investing Activities
Capital Expenditures (Quarter)
0.04M
Change in Acquisitions & Divestments (Quarter)
68.20M59.35M78.70M38.50M34.50M40.48M30.50M1.14M19.72M32.49M20.68M8.32M11.73M-0.77M34.78M
Cash from Investing Activities (Quarter)
-0.16M
Financing Activities
Other financing activities (Quarter)
188.54M-0.06M0.01M1.93M
Change in Capital Stock
Shares Issued (Quarter)
15.90M
Net Equity Issued and Repurchased (Quarter)
46.76M-46.76M46.76M0.91M47.89M-47.89M104.15M
Misc.
Cash from Financing Activities (Quarter)
0.91M
Change in Cash (Quarter)
-2.80M
Free Cash Flow (Quarter)
-3.59M
Net Cash Flow (Quarter)
-2.80M